HTTIF (HighTide Therapeutics) OCF Yield %: -12.15 (As of Jun. 25, 2026)


HTTIF HighTide Therapeutics Inc HTTIF
14 GF Score
Price $0.35
! 3 Warning Signs
View Full Analysis

What is HighTide Therapeutics OCF Yield %?

HighTide Therapeutics HTTIF 14 OCF Yield % is -12.15 as of Jun. 25, 2026. GuruFocus rates HTTIF with a GF Score™ of 14/100. The stock has 3 warning signs investors should review. Among 1,418 Biotechnology companies, HighTide Therapeutics ranks worse than 58.82% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, HighTide Therapeutics's Trailing 12-Month Cash Flow from Operations is $-23.37 Mil, and Market Cap is $192.08 Mil. Therefore, HighTide Therapeutics's OCF Yield % for today is -12.15%.

The historical rank and industry rank for HighTide Therapeutics's OCF Yield % or its related term are showing as below:

HTTIF' s OCF Yield % Range Over the Past 10 Years
Min: -12.15   Med: 0   Max: -12.15
Current: -12.15


During the past 5 years, the highest OCF Yield % of HighTide Therapeutics was -12.15%. The lowest was -12.15%. And the median was %.

HTTIF's OCF Yield % is ranked worse than
58.82% of 1418 companies
in the Biotechnology industry
Industry Median: -8.55 vs HTTIF: -12.15

HighTide Therapeutics's OCF Margin % for the quarter that ended in Dec. 2025 was %.


HighTide Therapeutics OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


HighTide Therapeutics OCF Yield % Related Terms


HighTide Therapeutics OCF Yield % Historical Data

* Premium members only.

The historical data trend for HighTide Therapeutics's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HighTide Therapeutics OCF Yield % Chart

HighTide Therapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
0.00 0.00 0.00 0.00 -11.55

HighTide Therapeutics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Yield % Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 -6.52

HTTIF vs VRTX, REGN, ALNY: OCF Yield % Comparison

For the Biotechnology subindustry, HighTide Therapeutics's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HighTide Therapeutics OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HighTide Therapeutics's OCF Yield % distribution charts can be found below:

* The bar in red indicates where HighTide Therapeutics's OCF Yield % falls into.


HTTIF
14GF Score
HighTide Therapeutics Inc HTTIF
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HighTide Therapeutics OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

HighTide Therapeutics's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-23.697 / 205.1647595
=-11.55%

HighTide Therapeutics's annualized OCF Yield % for the quarter that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-6.69 * 2 / 205.1647595
=-6.52%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -12.15 mean?
HighTide Therapeutics (HTTIF) has a OCF Yield % of -12.15 as of Jun. 25, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on HighTide Therapeutics and its competitors. According to the industry distribution chart, HighTide Therapeutics ranks #834 out of 1418 companies in the Biotechnology industry, placing it in the top 58.8%.
Is HighTide Therapeutics' OCF Yield % too high?
HighTide Therapeutics' current OCF Yield % is -12.15. Based on the distribution chart, HighTide Therapeutics ranks #834 out of 1418 companies in the Biotechnology industry, which is below the industry midpoint. Overall, HighTide Therapeutics has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does HighTide Therapeutics' OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, HighTide Therapeutics ranks #834 out of 1418 companies for OCF Yield %. This places HighTide Therapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on HighTide Therapeutics and its competitors. HighTide Therapeutics's current OCF Yield % is -12.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HighTide Therapeutics stock overvalued right now?
HighTide Therapeutics (HTTIF) has a current OCF Yield % of -12.15. The current OCF Yield % is -12.15. HighTide Therapeutics' overall GF Score™ is 14/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For HighTide Therapeutics (HTTIF), the current OCF Yield % is -12.15 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HighTide Therapeutics Business Description

Other Exchanges 02511:Hong Kong
Address Fubao Street, 9th to 10th Floor, Building D, Shenfang Park, Futian District, Shenzhen-Hong Kong Science and, Technology Innovation Cooperation Zone, Guangdong, Shenzhen, CHN, 518112
HighTide Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of first-in-class multifunctional, multi-targeted therapies for cardiovascular-kidney-metabolic (CKM) diseases and related metabolic disorders. The company is developing a pipeline of proprietary drug candidates targeting indications including type 2 diabetes mellitus, chronic kidney disease, obesity, metabolic dysfunction-associated steatohepatitis (MASH), and primary sclerosing cholangitis (PSC). Its core product candidate, HTD1801 (berberine ursodeoxycholate), is an orally delivered first-in-class anti-inflammatory metabolic modulator designed to target dual pathways involving AMPK activation and NLRP3 inflammasome inhibition.
14GF Score

Get the complete analysis for HTTIF

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.35
Price